Who is on this subjectordered by the date of their first quote here
1 of 2 lane rests on fewer than 5 quotes and is marked thin. Offsets are days from the middle first-quote date, 21 May 2020 — a date, and nothing else. It is not a claim about who reached a view first.
-
David Friedberg
7
21 May 2020 – 18 Jul 2026
+0 d
- Sir Richard Dearlove 2 thin 3 Jun 2020 – 3 Jun 2020 +13 d
The chronologysourced and dated, oldest first
-
-
David Friedberg
Friedberg cites recent paper showing 40-60% of population has T-cell immunity to COVID from prior common cold exposure.
“And the reason is that they've had other coronaviruses through a common cold and they've developed this immune response.”
-
David Friedberg
Friedberg reports 40-60% of people have pre-existing T-cell immunity to COVID-19 from prior coronavirus exposure.
“forty to sixty percent of the population that has never been exposed to SARS coronavirus to the current coronavirus already have activated T cells to the virus.”
-
Sir Richard Dearlove
Dearlove endorses a peer-reviewed scientific paper on virus origins as a very important contribution to the debate.
“I think that the importance of the paper is that it is written by two very knowledgeable scientists, one a world leading virologist. Well, both of them are actually. It's been peer reviewed extensively.”
-
Sir Richard Dearlove
Dearlove says scientific paper on virus origins is important and will shift debate on pandemic evolution.
“I'm not a scientist, I'm not really prepared to speculate very far, but I think this particular article is very important, and I think it will shift the debate.”
-
-
-
David Friedberg
Friedberg states Chinese scientific publications went from half of US levels in 2015 to 50% more than US now.
“a statistic. In twenty fifteen, ten years ago, papers published by Chinese research labs and major scientific journals were about half of The United States. Yeah. Now 50% more than The United States.”
-
-
-
David Friedberg
Friedberg explains scientists created an enzyme to break down CML, the predominant aging molecule that nothing naturally degrades.
“CML is kind of the predominant molecule that gets formed in this extracellular matrix that's driving aging, and nothing breaks it down. So these scientists set out to try and create an enzyme.”
-
David Friedberg
Friedberg explains scientists created enzyme to break down CML using DNA programming where three letters code for amino acids.
“An enzyme is a protein that breaks something down, that can break down CML. And remember, a protein is just a series of amino acids, and those amino acids are programmed by DNA.”
-
David Friedberg
Friedberg reports the enzyme eliminated 52 to 97% of aging molecules in human body proteins after five optimization cycles.
“And they did this recursively five different cycles, and then eventually they tested it once they kinda gotten it breaking down the CML really well in a test tube.”
-
David Friedberg
Friedberg explains CML is the predominant aging molecule in extracellular matrix that nothing naturally breaks down.
“CML is kind of the predominant molecule that that gets formed in this extracellular matrix that's driving aging, and nothing breaks it down. So these scientists set out to try and create an enzyme.”
-